Physician-community pharmacist collaborative care in diabetes management: a pilot study

Bouchra Bakr Mouhtadi, Malak M Alame, Bassem Malaeb, Souheil Hallit, Pascale Salameh, Diana Malaeb, Bouchra Bakr Mouhtadi, Malak M Alame, Bassem Malaeb, Souheil Hallit, Pascale Salameh, Diana Malaeb

Abstract

Background: Attaining therapeutic goals in diabetes mellitus (DM) is often suboptimal due to disease complexity, poor adherence and inadequate patient counseling. Aim: This study evaluated the effectiveness of the collaboration between the physicians and pharmacists in DM management. Design and setting: A pilot study was conducted between January 2015 and December 2015 in diabetic patients from four districts of Lebanon. Methods: A total of 200 patients with type 2 DM were recruited with 12 months of follow-up. A range of clinical measures, including medication adherence and self-care activities, were assessed over a period of 12 months. The protocol consisted of primary care physicians referring patients to community pharmacies. The participants were attended for 30 min in the pharmacy. They were asked to complete a questionnaire and then received counseling on their illness and their medication in an organized manner by the pharmacist once every month for 12 consecutive months. The primary outcome was the change in fasting blood glucose (FBG) after 12 months of follow-up. Results: A total of 200 patients completed the study. The primary endpoint decreased significantly from the baseline after 12 months of follow-up (mean difference: 30 mg/dl; 95% CI, 28-32; p < .001). The secondary endpoints, such as glycated hemoglobin, also showed an improvement after 12 months of follow-up. Conclusion: Collaborative care between the physician and the pharmacist was successful in reducing FBG and improving patient satisfaction and quality of care over 12 months of follow-up.

Keywords: Pharmacist role; diabetes mellitus; fasting blood glucose; intervention.

References

    1. American Diabetes Association Standards of Medical Care in Diabetes—2008. Diabetes Care. 2008;31:S12-S54.
    1. Koopmanschap M. Coping with type II diabetes: the patient's perspective. Diabetologia. 2002;45:S18-S22.
    1. Pasquale LR, Kang JH, Manson JE, et al. . Prospective study of type 2 diabetes mellitus and risk of primary open-angle glaucoma in women. Ophthalmology. 2006;113:1081-1086.
    1. MacIsaac RJ, Panagiotopoulos S, McNeil KJ, et al. . Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease? Diabetes Care. 2006;29:1560-1566.
    1. Cho YN, Lee KO, Jeong J, et al. . The role of insulin resistance in diabetic neuropathy in Koreans with type 2 diabetes mellitus: a 6-year follow-up study. Yonsei Med J. 2014;55:700-708.
    1. Franco OH, Steyerberg EW, Hu FB, et al. . Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med. 2007;167:1145-1151.
    1. Bamberg F, Parhofer KG, Lochner E, et al. . Diabetes mellitus: long-term prognostic value of whole-body MR imaging for the occurrence of cardiac and cerebrovascular events. Radiology. 2013;269:730-737.
    1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4-14.
    1. Harb H. Compiled literature report on selected health conditions in Lebanon. Lebanese Ministry of Public Health, Directorate of Prevention, Department of Statistics. 2004;115.
    1. IDF Mena members International Diabetes Federation.2017. Lebanon-39. Available at:
    1. Costanian C, Bennett K, Hwalla N, et al. . Prevalence, correlates and management of type 2 diabetes mellitus in Lebanon: findings from a national population-based study. Diabetes Res Clin Pract. 2014;105:408-415.
    1. Funnell MM, Brown TL, Childs BP, et al. . National standards for diabetes self-management education. Diabetes Care. 2011;34:S89-S96.
    1. Armor BL, Britton ML, Dennis VC, et al. . A review of pharmacist contributions to diabetes care in the United States. J Pharm Pract. 2010;23:250-264.
    1. Clifford RM, Davis WA, Batty KT, et al. . Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2005;28:771-776.
    1. Krass I, Armour CL, Mitchell B, et al. . The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabetic Med. 2007;24:677-683.
    1. Choe HM, Mitrovich S, Dubay D, et al. . Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care. 2005;11:253-260.
    1. Fornos JA, Andrés NF, Andrés JC, et al. . A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain. Pharm World Sci. 2006;28:65-72.
    1. Odegard PS, Goo A, Hummel J, et al. . Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother. 2005;39:433-440.
    1. Scott DM, Boyd ST, Stephan M, et al. . Outcomes of pharmacist-managed diabetes care services in a community health center. Am J Health Syst Pharm. 2006;63:2116-2122.
    1. Al Mazroui NR, Kamal MM, Ghabash NM, et al. . Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus. Br J Clin Pharmacol. 2009;67:547-557.
    1. Jameson JP, Baty PJ. Pharmacist collaborative management of poorly controlled diabetes mellitus: a randomized controlled trial. Am J Manag Care. 2010;16:250-255.
    1. Santschi V, Chiolero A, Paradis G, et al. . Pharmacist interventions to improve cardiovascular disease risk factors in diabetes. Diabetes Care. 2012;35:2706-2717.
    1. Wagner EH, Austin BT, Davis C, et al. . Improving chronic illness care: translating evidence into action. Health Aff (Millwood). 2001;20:64-78.
    1. Renders CM, Valk GD, Griffin SJ, et al. . Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care. 2001;24:1821-1833.
    1. McCord AD. Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service. Pharmacotherapy. 2006;26:248-253.
    1. Palaian S, Chhetri AK, Prabhu M. et al. . Role of pharmacist in counseling diabetes patients. Internet J Pharmacol. 2004;4:3272.
    1. Arun KP, Murugan R, Kanna MR, et al. . The impact of pharmaceutical care on the clinical outcome of diabetes mellitus among a rural patient population. Int J Diabetes Dev Ctries. 2008;28:15-18.
    1. Smith M. Pharmacists’ role in improving diabetes medication management. J Diabetes Sci Technol. 2009;3:175-179.
    1. Malathy R, Narmadha M, Ramesh S, et al. . Effect of a diabetes counseling programme on knowledge, attitude and practice among diabetic patients in Erode district of South India. J Young Pharm JYP. 2011;3:65-72.
    1. Jarab AS, Alqudah SG, Mukattash TL, et al. . Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. JMCP. 2012;18:516-526.
    1. Obreli-Neto PR, Guidoni CM, de Oliveira, Baldoni A, et al. . Effect of a 36-month pharmaceutical care program on pharmacotherapy adherence in elderly diabetic and hypertensive patients. Int J Clin Pharm. 2011;33:642-649.
    1. Grant RW, Devita NG, Singer DE, et al. . Improving adherence and reducing medication discrepancies in patients with diabetes. Ann Pharmacother. 2003;37:962-969.
    1. Omran D, Guirguis LM, Simpson SH. Systematic review of pharmacist interventions to improve adherence to oral antidiabetic medications in people with type 2 diabetes. Can J Diabetes. 2012;36:292-299.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera